How Can We Encourage COVID-19 Vaccine Developers to Expand Manufacturing Capacity?
“The benefits of vaccine manufacturing capacity expansion are much higher to society than to a vaccine developer. Underinvestment in manufacturing capacity which leads to slower pace of vaccination creates an average monthly GDP loss of $500 billion—a cost borne by all of society.”
